Literature DB >> 12801742

Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Abeta to physiologically relevant proteolytic degradation.

Satoshi Tsubuki1, Yoshie Takaki, Takaomi C Saido.   

Abstract

The Dutch, Flemish, Italian, and Arctic mutations in the amyloid precursor protein (APP) gene encode changes within the sequence of the amyloid beta peptide (Abeta) and cause presenile cerebral amyloid angiopathy, cerebral parenchymal amyloidosis, or both. These disorders are caused by accumulation of Abeta, with no evidence of increased Abeta production. Our results showed that these mutations in Abeta make it resistant to proteolytic degradation by neprilysin, the peptidase with the most important role in catabolism of Abeta in the brain. These mutations in Abeta could thus be pathogenic not only by facilitating fibrillogenesis but also by extending the half-life of Abeta in the brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12801742     DOI: 10.1016/s0140-6736(03)13555-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  43 in total

1.  Polymorphic triple beta-sheet structures contribute to amide hydrogen/deuterium (H/D) exchange protection in the Alzheimer amyloid beta42 peptide.

Authors:  Buyong Ma; Ruth Nussinov
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

2.  On the nucleation of amyloid beta-protein monomer folding.

Authors:  Noel D Lazo; Marianne A Grant; Margaret C Condron; Alan C Rigby; David B Teplow
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

3.  Solvent-free MALDI-MS for the analysis of beta-amyloid peptides via the mini-ball mill approach: qualitative and quantitative advances.

Authors:  Sarah Trimpin; Max L Deinzer
Journal:  J Am Soc Mass Spectrom       Date:  2007-04-29       Impact factor: 3.109

4.  Familial Alzheimer's Disease Mutations within the Amyloid Precursor Protein Alter the Aggregation and Conformation of the Amyloid-β Peptide.

Authors:  Asa Hatami; Sanaz Monjazeb; Saskia Milton; Charles G Glabe
Journal:  J Biol Chem       Date:  2017-01-03       Impact factor: 5.157

5.  Tg-SwDI transgenic mice exhibit novel alterations in AbetaPP processing, Abeta degradation, and resilient amyloid angiopathy.

Authors:  Gregory D Van Vickle; Chera L Esh; Ian D Daugs; Tyler A Kokjohn; Walter M Kalback; R Lyle Patton; Dean C Luehrs; Douglas G Walker; Lih-Fen Lue; Thomas G Beach; Judianne Davis; William E Van Nostrand; Eduardo M Castaño; Alex E Roher
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

Review 6.  Three dimensions of the amyloid hypothesis: time, space and 'wingmen'.

Authors:  Erik S Musiek; David M Holtzman
Journal:  Nat Neurosci       Date:  2015-06       Impact factor: 24.884

Review 7.  Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.

Authors:  Jessica Nasica-Labouze; Phuong H Nguyen; Fabio Sterpone; Olivia Berthoumieu; Nicolae-Viorel Buchete; Sébastien Coté; Alfonso De Simone; Andrew J Doig; Peter Faller; Angel Garcia; Alessandro Laio; Mai Suan Li; Simone Melchionna; Normand Mousseau; Yuguang Mu; Anant Paravastu; Samuela Pasquali; David J Rosenman; Birgit Strodel; Bogdan Tarus; John H Viles; Tong Zhang; Chunyu Wang; Philippe Derreumaux
Journal:  Chem Rev       Date:  2015-03-19       Impact factor: 60.622

8.  Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onset.

Authors:  Guoqiao Wang; Dean Coble; Eric M McDade; Jason Hassenstab; Anne M Fagan; Tammie L S Benzinger; Randall J Bateman; John C Morris; Chengjie Xiong
Journal:  Alzheimers Dement       Date:  2019-02-15       Impact factor: 21.566

Review 9.  Network abnormalities and interneuron dysfunction in Alzheimer disease.

Authors:  Jorge J Palop; Lennart Mucke
Journal:  Nat Rev Neurosci       Date:  2016-11-10       Impact factor: 34.870

Review 10.  APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.

Authors:  Leslie Crews; Edward Rockenstein; Eliezer Masliah
Journal:  Brain Struct Funct       Date:  2009-11-29       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.